Angioimmunoblastic T-cell lymphoma
MONDO:0004977A mature T-cell non-Hodgkin lymphoma, characterized by systemic disease and a polymorphous infiltrate involving lymph nodes and extranodal sites. The clinical course is typically aggressive.
Also known as: AILD, AILT, T-cell lymphoma, AILD type, angioimmunoblastic T-cell lymphoma, angioimmunoblastic lymphadenopathy, angioimmunoblastic lymphadenopathy type T-cell lymphoma, angioimmunoblastic lymphadenopathy with Dysproteinemia, immunoblastic lymphadenopathy
1986 clinical trials for this condition and its sub-types, 58 tagged with Angioimmunoblastic T-cell lymphoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Lymphoma drug duvelisib tested after transplant – trial ends early
Disease control Stopped earlyThis phase 2 trial tested the drug duvelisib (Copiktra) as a maintenance therapy after an autologous stem cell transplant in 17 people with T-cell lymphoma. The goal was to see if it could safely delay the cancer from coming back. The study was terminated early, so the full resul…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Experimental CAR T-Cell therapy targets tough lymphoma
Disease control Stopped earlyThis early-phase trial tested a new treatment called AUTO4 for people with a type of T-cell lymphoma that had come back or not responded to prior therapy. AUTO4 is a CAR T-cell therapy designed to recognize and attack cancer cells carrying a specific marker called TRBC1. The stud…
Phase 1/2 • Sponsor: Autolus Limited • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC